CRG
ABBV icon

Cornerstone Retirement Group’s AbbVie ABBV Stock Holding History

Cornerstone Retirement Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$322K Buy
2,160
+22
+1% +$3.23K 0.09% 20
2023
Q2 		$288K Buy
2,138
+117
+6% +$17.2K 0.08% 15
2023
Q1 		$322K Hold
2,021
– – 0.09% 7
2022
Q4 		$327K Buy
+2,021
New +$310K 0.1% 6

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Retirement Group's ABBV Position: Q3 2023 in Review

Cornerstone Retirement Group increased its AbbVie (ABBV) stake by 1% in Q3 2023, buying an estimated $3.23K and bringing the position to 2,160 shares worth $322K. The position accounts for 0.09% of the portfolio, ranked #20.

Cornerstone Retirement Group first reported a position in ABBV in Q4 2022 and has held it in 4 quarters since. The position peaked at $327K in Q4 2022. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Cornerstone Retirement Group held 2,160 shares of AbbVie worth $322K as of Q3 2023.
  • Cornerstone Retirement Group bought 22 AbbVie shares in Q3 2023, an estimated $3.23K.
  • AbbVie made up 0.09% of Cornerstone Retirement Group's portfolio in Q3 2023, its #20 holding.
  • Cornerstone Retirement Group first reported a position in AbbVie in Q4 2022 and has held it in 4 quarters since.
  • Cornerstone Retirement Group's AbbVie position peaked at $327K in Q4 2022.
  • 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Cornerstone Retirement Group's 13F filing for Q3 2023, filed 26 Oct 2023.